World's Best Scientists 2026 revealed!
Contemporary Clinical Trials Communications
H-index 18

Contemporary Clinical Trials Communications

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1500 261 212 16

Additional Metrics

Number of Best Scientists*: 576
Documents by Best Scientists*: 394
Top 100 Ranked Scientists*: 15
SCIMAGO H-index: 30
SCIMAGO SJR: 0.59
Impact Factor: 1.4

Overview

Top Research Topics at Contemporary clinical trials communications?

The journal is mainly concerned with subjects like Randomized controlled trial, Clinical trial, Physical therapy, Intervention (counseling) and Internal medicine. The research on Randomized controlled trial tackled can also make contributions to studies in the areas of Psychological intervention, Quality of life, Gerontology and Protocol (science). The studies in Clinical trial featured incorporate elements of Clinical research, Health care, Family medicine, Medical education and Intensive care medicine.

Contemporary clinical trials communications links adjacent topics like Intervention (counseling) with Disease. While Internal medicine is the focus of Contemporary clinical trials communications, it also provided insights into the studies of Placebo and Oncology.

  • Randomized controlled trial (39.45%)
  • Clinical trial (35.61%)
  • Physical therapy (19.54%)

What are the most cited papers published in the journal?

  • Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review (176 citations)
  • Different ways to estimate treatment effects in randomised controlled trials. (112 citations)
  • Exercise training as S-Klotho protein stimulator in sedentary healthy adults: Rationale, design, and methodology. (46 citations)

Research areas of the most cited articles at Contemporary clinical trials communications:

The main points discussed in the published papers deal with Clinical trial, Randomized controlled trial, Physical therapy, Family medicine and Gerontology. The most cited publications focus on Clinical trial but the discussions also offer insight into other areas such as Psychological intervention, Health care, Informed consent, Intensive care medicine and Placebo. In particular, the Randomized controlled trial works presented in the published papers emphasize discussions on Blinding.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Statistics
  • Cancer

The previous edition focused in particular on these issues:

The main points discussed in the journal deals with Randomized controlled trial, Clinical trial, Intervention (counseling), Physical therapy and Protocol (science). The overlapping concepts between Mental health and Clinical psychology are the key highlights of Randomized controlled trial study. The featured Clinical trial study falls within the wider topic of Internal medicine.

Research in Placebo and the interrelating topic of Diabetes mellitus were among the subjects of interest in the Internal medicine studies discussed in Contemporary clinical trials communications. It focuses on Intervention (counseling) but sometimes tackles the closely related topic of Gerontology which is concerned with Attendance. Issues in Physical therapy were discussed, taking into consideration concepts from other disciplines like Obesity, Cohort and Telehealth.

The most cited articles from the last journal are:

  • Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol (8 citations)
  • Identification of biomarkers specific to five different nicotine product user groups: Study protocol of a controlled clinical trial. (2 citations)
  • Design, methods, and baseline characteristics of a pilot, randomized, controlled trial of the effects of an electronic monitoring device on medication adherence in children with asthma. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Contemporary clinical trials communications (based on the number of publications) are:

  • Amy Corneli (10 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Lehana Thabane (9 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Jane Nikles (7 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Grant D. Huang (6 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Pearl A. McElfish (6 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Contemporary clinical trials communications (based on the number of publications) are:

  • Harvard University (32 papers) published 8 papers at the last edition, 1 less than at the previous edition,
  • Duke University (31 papers) published 8 papers at the last edition, 2 less than at the previous edition,
  • Veterans Health Administration (27 papers) published 7 papers at the last edition the same number as at the previous edition,
  • Boston Children's Hospital (23 papers) published 9 papers at the last edition, 4 more than at the previous edition,
  • University of North Carolina at Chapel Hill (21 papers) published 4 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.70% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.27% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.42% of all publications and 42.96% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Paths Inspired by Contemporary Clinical Trials Communications

Aspiring healthcare professionals and researchers may find the studies published in Contemporary Clinical Trials Communications inspiring. The depth and breadth of topics covered offer great insights into critical fields of study that pave the way for significant careers. For instance, reading about a randomized controlled trial in Internal Medicine could be the spark that leads someone to explore the path to becoming a nurse practitioner.

The case studies of those who have taken the journey can provide valuable insights along the way. For instance, understanding how to be a nurse practitioner in Kentucky can be a great resource when gauging a potential career pathway. Therefore, the link between academic research and practical applications in the real world of healthcare cannot be understated.

Moreover, the focus on patient-centric care resonating from studies on Intervention (counseling), Physical Therapy, and Gerontology highlights other potential career paths. These include counseling roles, physical therapy, and roles in elderly care, all of which are growing in demand as health systems across the globe evolve.

Overall, Contemporary Clinical Trials Communications not only provides rich academic content but also serves as a catalyst for career ideas and progression in a multitude of healthcare-related professions.

Top Publications

  • The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.

    Robert M. Haws;Gregory Gordon;Joan C. Han;Joan C. Han;Jack A. Yanovski

    (2021)
    35 Citations
  • Intention-to-treat analysis when only a baseline value is available

    Jos Wr. Twisk;Judith Jm. Rijnhart;Trynke Hoekstra;Noah A. Schuster

    (2020)
    35 Citations
  • Establishment of an International Collaborative Network for N-of-1 Trials and Single-Case Designs.

    Jane Nikles;Patrick Onghena;Johan W.S. Vlaeyen;Johan W.S. Vlaeyen;Rikard K. Wicksell

    (2021)
    33 Citations
  • A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design.

    Inga Peter;Ana Maldonado-Contreras;Caroline Eisele;Christine Frisard

    (2020)
    32 Citations
  • NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy.

    Corrado Tinterri;Giuseppe Canavese;Paolo Bruzzi;Beatrice Dozin

    (2020)
    28 Citations
  • A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.

    Miko Yamada;Dennis M. Miller;Melinda Lowe;Casey Rowe

    (2021)
    25 Citations
  • Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions.

    Wei Liu;Shangyuan Ye;Bruce A. Barton;Melissa A. Fischer

    (2020)
    25 Citations
  • Does prospective acceptability of an intervention influence refusal to participate in a randomised controlled trial? An interview study.

    Mandeep Sekhon;Martin Cartwright;Sadie Lawes-Wickwar;Hayley McBain

    (2021)
    22 Citations
  • Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

    Alkomiet Hasan;Alkomiet Hasan;Astrid Roeh;Stefan Leucht;Berthold Langguth

    (2020)
    20 Citations
  • Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis

    (2023)
    20 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can open diverse career opportunities. A popular starting point is becoming a nurse, with many students opting for registered nurse online programs. These programs offer flexibility and foundational clinical skills essential for healthcare.

Nutrition is another critical area tied to medicine, and earning a nutritionist degree online equips students to promote health through diet and lifestyle, complementing medical treatment.

For those aiming at leadership roles within healthcare, pursuing a Master of Healthcare Administration (MHA) is beneficial. Ensuring the program’s quality is key, which is why selecting cahme accreditation for mha programs is important to guarantee rigorous standards and industry recognition.

Advanced practice nurses may consider online dnp programs without dissertation, allowing them to achieve a Doctor of Nursing Practice degree with greater flexibility, especially for working professionals balancing clinical responsibilities.

Best Scientists Contributing to This Journal